To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Hadeel Assad, M.D. , medical oncologist, member of the Breast Cancer Multidisciplinary Team (MDT) and Phase 1 Clinical Trials Program at Karmanos, along with hematology and medical oncology graduating fellow at Karmanos and Wayne State University (WSU) School of Medicine, Bayan Al-Share, M.D., co-authored “Role of High-Dose Adjuvant Chemotherapy (HDC) Followed by Autologous Stem Cell Transplantation (ASCT) in Locally Advanced Triple-Negative Breast Cancer (TNBC): A Retrospective Chart Review,” published...
The Barbara Ann Karmanos Cancer Institute has been awarded a $325,372 grant from U CAN-CER VIVE Foundation. The funds will support cancer research focused on diffuse large B cell lymphoma (DLBCL). "We continue to be amazed by the work the dedicated doctors and researchers at Karmanos have made and are optimistic that this new grant will provide the support they need to continue their lifesaving research,” said Kelley LaFontaine, co-founder, U CAN-CER VIVE. “We take great pride in knowing that each dolla...